Clinical Trial Update: Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing anastrozole plus fulvestrant versus anastrozole alone as adjuvant therapy in postmenopausal breast cancer; results completed and posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-01-22